A significant breakthrough in cancer study is emerging with the use of nanobodies to reactivate damaged p53. This vital cancer suppressor protein is frequently inactivated in various types of malignancies, leading https://bookmarkcitizen.com/story21935749/mini-antibodies-revive-tumor-suppressor-p53-the-promising-approach-for-malignant-therapy